Huang Rongrong, Chen Ranran, Xing Lijuan, Wu Lianhao, Zhu Wenwen, Jing Junsong, Zhou Ting, Wu Yueguo, Zhang Sheng, You Zhenqiang
School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical College, Hangzhou, China.
School of Public Health, Hangzhou Medical College, Hangzhou, China.
Front Immunol. 2025 Jul 1;16:1598902. doi: 10.3389/fimmu.2025.1598902. eCollection 2025.
Viral pneumonia is the most common and lethal pandemic disease, but there are no broad-spectrum antiviral drugs with high genetic barriers to resistance. To elucidate the mechanisms of viral pneumonia progression and potential targets for its treatment.
Viral pneumonia models were induced by the PR8 virus strain in wild-type (WT) and STING knockout (STING-KO) mice. Series of molecular biology techniques were used to evaluate the severity of pneumonia and cytokine levels.
In this study, STING (stimulator of interferon genes) was activated in the lungs of virus-infected mice, leading to cytokine production and amplification of the immune response, thereby causing rapid deterioration of symptoms. Furthermore, excessive activation of innate immune response via STING was prevented by a STING inhibitor (C-176), which significantly reduced viral lung inflammation. The formation of neutrophil extracellular traps (NETs) was similarly suppressed during viral pneumonia treatment with STING inhibitors (C-176), and NETs formation and STING expression were positively correlated, indicating that STING plays an important role in NETs formation. Symptoms of pneumonia in STING-KO mice infected with PR8 were significantly milder than those in WT mice, and NETs were less likely to form in the lung tissue of STING-KO mice. Additionally, transcriptomic analysis revealed that STING-mediated regulation of NETs may be associated with gasdermin D (GSDMD), and immunoprecipitation experiments revealed that STING, GSDMD, and NETs-related proteins interact with each other. Immunofluorescence assays revealed that in neutrophils from WT mice, STING and GSDMD were colocalized on the membrane after viral infection, whereas in neutrophils from STING-KO mice, GSDMD expression was decreased after exposure to the virus.
Our study demonstrated that targeted intervention with STING alleviated pneumonia by inhibiting inflammation and NETs formation. The study also revealed that blocking STING could inhibit the activation of GSDMD to inhibit NETs formation, slowing the progression of viral pneumonia.
病毒性肺炎是最常见且致命的大流行性疾病,但目前尚无具有高耐药基因屏障的广谱抗病毒药物。为阐明病毒性肺炎进展的机制及其潜在治疗靶点。
用PR8病毒株在野生型(WT)和STING基因敲除(STING-KO)小鼠中诱导病毒性肺炎模型。采用一系列分子生物学技术评估肺炎严重程度和细胞因子水平。
在本研究中,病毒感染小鼠的肺中STING(干扰素基因刺激因子)被激活,导致细胞因子产生和免疫反应放大,从而使症状迅速恶化。此外,STING抑制剂(C-176)可阻止通过STING过度激活先天免疫反应,显著减轻病毒性肺部炎症。在用STING抑制剂(C-176)治疗病毒性肺炎期间,中性粒细胞胞外陷阱(NETs)的形成同样受到抑制,且NETs形成与STING表达呈正相关,表明STING在NETs形成中起重要作用。感染PR8的STING-KO小鼠的肺炎症状明显轻于WT小鼠,且STING-KO小鼠肺组织中形成NETs的可能性较小。此外,转录组分析显示STING介导的NETs调节可能与gasdermin D(GSDMD)有关,免疫沉淀实验显示STING、GSDMD和NETs相关蛋白相互作用。免疫荧光分析显示,在WT小鼠的中性粒细胞中,病毒感染后STING和GSDMD共定位于细胞膜,而在STING-KO小鼠的中性粒细胞中,病毒感染后GSDMD表达降低。
我们的研究表明,靶向干预STING可通过抑制炎症和NETs形成来减轻肺炎。该研究还表明,阻断STING可抑制GSDMD的激活以抑制NETs形成,减缓病毒性肺炎的进展。